| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 400 | $90 | $34.3K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 130 | $170 | $21.6K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 100 | $130 | $12.5K |
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 20 | $250 | $4.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 40 | $100 | $4.5K |
| 51702 | The bladder catheter CPT® codes provide options for reporting the procedures that best reflect the exact anatomic location of a catheter insertion, the type of catheter inserted, and, in some cases,… | 90 | $40 | $4K |
| 55700 | Code deleted December 31, 2025. | 20 | $160 | $3.5K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 50 | $70 | $3.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 50 | $70 | $3.2K |
| 52235 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 10 | $210 | $2.9K |